26586-36-7

Upstream product

• 14062-25-0 Ethyl 4-bromophenylacetate 
• 866831-58-5 methyl 2-(4-(pyrrolidin-1-yl)phenyl)acetate 
• 5438-70-0 ethyl (4-amino-3,5-dibromophenyl)acetate 
• 123-75-1 pyrrolidine 
• 1878-68-8 2-(4-bromophenyl)-acetic acid 

Downstream Products

• 1190069-91-0 N-{4-[(difluoromethyl)thio]phenyl}-2-(4-pyrrolidin-1-ylphenyl)acetamide 
• 877859-95-5 3-[2-(4-pyrrolidin-1-yl-phenyl)-acetylamino]-4,6-dihydro-pyrrolo[3,4-c]pyrazole-1,5-dicarboxylic acid 5-tert-butyl ester 1-ethyl ester 
• 877859-96-6 3-[2-(4-pyrrolidin-1-yl-phenyl)-acetylamino]-4,6-dihydro-pyrrolo[3,4-c]pyrazole-1-carboxylic acid ethyl ester 
• 877859-93-3 4-(pyrrolidin-1-yl)phenylacetic acid chloride 
• 1028279-46-0 N-[5-(2,4-Dioxo-thiazolidin-5-ylmethyl)-2-hydroxy-phenyl]-2-(4-pyrrolidin-1-yl-phenyl)-acetamide 

Relevant academic research and scientific papers

Decarboxylative allylation of amino alkanoic acids and esters via dual catalysis

A combination of photoredox and palladium catalysis has been employed to facilitate the room temperature decarboxylative allylation of recalcitrant amino and phenylacetic allyl esters. This operationally simple process produces CO2as the only b

Visible light-mediated oxidative decarboxylation of arylacetic acids into benzyl radicals: Addition to electron-deficient alkenes by using photoredox catalysts

Reactions of arylacetic acids bearing an amino group at the para-position in the benzene ring with alkenes in the presence of a catalytic amount of transition metal polypyridyl complexes as photocatalysts under visible light illumination proceed smoothly to give the corresponding benzylated products via oxidative decarboxylation in good to high yields.

ANILINE DERIVATIVES

The present invention provides a novel compound having a kininogenase-inhibitory action and its pharmaceutical use. The compounds represented by the formulas (A), (B), (C), (E) and (H) : wherein each symbol is as defined in the specification, or a pharmac

DIHYDRODIARYLOXAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THE DERIVATIVE

The present invention provides dihydrodiaryloxazepine derivative represented by the following formula [1], analogs thereof and pharmaceutical compositions containing them. Those compounds have an excellent effect of improving functional diseases of gastro